Baicalin alleviates Trueperella pyogenes-induced endometritis with associated changes in gut microbiota composition Authors: Ziqi Peng, Chunyang Gou, Yisong Guan, Yueting Wang, Yanan Liu, Fucheng Wang, Ruibin Wang, Maozhen Qi Published: 2026 ABSTRACT BackgroundEndometritis is a prevalent reproductive disorder in livestock characterized by inflammation, oxidative stress, and microbial imbalance; however, the mechanistic links among these processes remain incompletely understood. This study investigated the protective effects of baicalin in a Trueperella pyogenes (T. pyogenes)-induced mouse model of endometritis by integrating network pharmacology, in vivo validation, and gut microbiota profiling.ResultsNetwork pharmacology analysis identified prostaglandin-endoperoxide synthase 2 (PTGS2, also known as cyclooxygenase-2, COX-2) and epidermal growth factor receptor (EGFR) as key targets of baicalin, with enrichment in arachidonic acid metabolism pathways. Baicalin treatment alleviated uterine pathology and suppressed inflammatory responses, as indicated by reduced tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and myeloperoxidase (MPO) activity. Baicalin also restored redox homeostasis by activating the Nrf2/Keap1/HO-1 pathway, increasing catalase (CAT) and superoxide dismutase (SOD) activities while decreasing malondialdehyde (MDA) levels, and concurrently reduced apoptosis, as evidenced by a lower ratio of Bcl-2-associated X protein (Bax) to B-cell lymphoma 2 (Bcl-2) (the Bax/Bcl-2 ratio). Concurrently, 16 S rRNA gene sequencing revealed that baicalin treatment was associated with alterations in gut microbiota composition, including changes in the relative abundance of several bacterial taxa linked to inflammation and metabolic functions. However, whether these microbial changes play a causal role in the observed protection remains to be determined.ConclusionsThese findings indicate that baicalin protects against endometritis through coordinated regulation of inflammation, oxidative stress, and apoptosis, and this protection was associated with shifts in gut microbiota composition. The results provide insight into the host-microbiota interactions accompanying endometritis and support baicalin as a potential therapeutic candidate, while highlighting the need for further causal investigations.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12917-026-05715-1. Introduction Endometritis is a prevalent inflammatory disorder that significantly impairs reproductive performance in livestock, particularly during the postpartum period, and is strongly associated with microbial infection and dysregulation of the uterine microenvironment [1]. During uterine involution, the local microbiota undergoes dynamic remodeling; disruption of this homeostasis facilitates the invasion and proliferation of opportunistic pathogens, including T. pyogenes, Escherichia coli, and Staphylococcus spp [2, 3]. In parallel, alterations in the gut microbiota have been increasingly implicated in modulating systemic immune responses and may influence susceptibility to extra-intestinal infections; however, gut and uterine microbial communities occupy distinct niches and are not interchangeable. Among these, T. pyogenes plays a central role in the pathogenesis of endometritis [4]. This pathogen produces virulence factors such as pyolysin, which disrupt epithelial integrity, induces neutrophil infiltration, and triggers inflammatory cascades, ultimately leading to tissue injury and reproductive dysfunction [5]. Natural products have garnered increasing attention owing to their pleiotropic pharmacological effects and ability to modulate both host immunity and gut microbial communities [6–8]. Accumulating evidence indicates that natural compounds can exert anti-inflammatory effects by reshaping gut microbial composition, reducing endotoxin levels, and regulating host immune responses [9–11]. For instance, inulin, honeysuckle, and green tea polyphenols have been reported to alleviate inflammatory conditions through gut microbiota modulation [12–14]. Baicalin, a major bioactive flavonoid derived from Scutellaria baicalensis, exhibits potent anti-inflammatory and immunomodulatory properties and has been shown to inhibit inflammation via regulation of NF-κB and MAPK signaling pathways [15, 16]. Although the anti-inflammatory effects of baicalin have been demonstrated in previous studies, its potential to modulate the gut microbiota during T. pyogenes-induced endometritis has not yet been explored. Whether the protective effects of baicalin against endometritis are accompanied by changes in gut microbiota composition, and whether such gut microbial shifts correlate with the attenuation of uterine inflammation, remains to be elucidated. However, the traditional pathogen-driven inflammatory framework does not fully account for the persistence and complexity of endometritis. Increasing evidence indicates that, beyond infection-induced inflammation, endometritis is also associated with uterine microbiota dysbiosis and dysregulated host immune responses [17, 18]. Uterine microbial imbalance can exacerbate inflammation by impairing short-chain fatty acid (SCFA) metabolism, compromising epithelial barriers, and modulating immune cell differentiation, particularly the Th17/Treg balance [19–22]. Accordingly, uterine microbiota-, immunity-, and inflammation-related processes have been increasingly recognized as critical regulators in endometritis; however, their integrated contributions to T. pyogenes-induced pathology remain insufficiently defined. Currently, antibiotic therapy remains the primary strategy for managing endometritis; however, the emergence of antimicrobial resistance and concerns over drug residues have become global challenges, limiting therapeutic efficacy and posing risks to animal health and food safety [23–26]. Consequently, alternative interventions with multi-target regulatory capacity and improved safety profiles are urgently needed [27]. With the rapid advancement of systems biology, integrative strategies that combine microbiome profiling with network pharmacology have emerged as powerful approaches for deciphering the mechanisms of multi-target agents [28, 29]. These frameworks enable systematic mapping of drug-target-pathway interactions and offer great potential for mechanistic dissection in inflammatory diseases [30, 31]. Therefore, a T. pyogenes-induced mouse model of endometritis was established, followed by integrative analyses of microbiome profiling and network pharmacology. We hypothesized that baicalin alleviates T. pyogenes-induced endometritis through multiple coordinated mechanisms, including the suppression of inflammation, reduction of oxidative stress, and inhibition of apoptosis. In parallel, we investigated whether these protective effects were accompanied by alterations in gut microbial composition. Materials and methods Network pharmacology integration analysis Potential protein targets of baicalin were predicted using SwissTargetPrediction with a probability threshold > 0.1. Target identifiers were standardized to official gene symbols using UniProt. Endometritis-related genes were retrieved from GeneCards with a relevance score > 1.0 to include a broad yet functionally relevant set of genes. Overlapping targets were used to construct a protein-protein interaction (PPI) network using STRING (medium confidence threshold: combined score > 0.4). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed using the clusterProfiler package with the whole human genome as the background set. P values were adjusted for multiple testing using the Benjamini-Hochberg method, and significantly enriched terms were identified at an adjusted P < 0.05. Animals, experimental design, and endometritis model Thirty specific pathogen-free (SPF) female Kunming mice (8 weeks old, 30–40 g) were obtained from the Second Affiliated Hospital of Harbin Medical University and maintained under controlled conditions (22 ± 2 °C, 50%-60% humidity, 12 h light/dark cycle) with ad libitum access to food and water. All experimental procedures were approved by the Animal Ethics Committee of Northeast Forestry University (approval No.:2023003). Baicalin (≥ 95% purity; Solarbio, Beijing, China) and T. pyogenes (provided by Northwest Agriculture and Forestry University) were used in this study. The baicalin dose (100 mg/kg) was selected based on prior studies demonstrating anti-inflammatory efficacy in murine models. Mice were randomly assigned to three groups (n = 10 per group)-control (CON), T. pyogenes-infected (TP), and baicalin-treated (BAI)-using a computer-generated random number sequence. Baicalin (≥ 95% purity; Solarbio, Beijing, China) was dissolved in DMSO to prepare a stock solution (25 mg/mL), which was further diluted with sterile saline to a final DMSO concentration of 60% (v/v) for oral administration. Mice in the BAI group received baicalin (100 mg/kg) in 60% DMSO in saline via oral gavage (0.1 mL per mouse) once daily for 14 consecutive days. Mice in the CON and TP groups received an equivalent volume of vehicle control (60% DMSO in saline) via the same route and schedule. At 24 h after the final gavage, endometritis was induced by intrauterine infusion of 20 µL T. pyogenes suspension (1 × 10¹⁰ CFU/mL), whereas control mice received sterile saline. Animals were anesthetized with isoflurane and euthanized by cervical dislocation 3 days post-infection. Uterine and cecal contents were then collected for subsequent analyses. Predefined exclusion criteria included severe body weight loss (> 20% within 72 h), abnormal behavior unrelieved by analgesia, or death. No animals met these criteria during the experimental period; therefore, no animals were excluded from the analyses. Body and organ weights were recorded for the calculation of organ indices. No adverse events were observed during the experimental period. Histopathological assessment of uterine injury Uterine tissues were fixed in 4% paraformaldehyde, paraffin-embedded, and sectioned at 4 μm, followed by hematoxylin and eosin staining. Histopathological alterations were evaluated under light microscopy (200 × magnification) by two independent assessors blinded to group allocation. For each animal, three randomly selected fields per uterine section were scored according to the rubric in Table 1. The total histopathological score for each animal was the sum of the five individual scores (range: 0–14). Scores from the two assessors were averaged for analysis. Table 1Histopathological scoring criteriaCriterionScoreDescriptionTissue hyperemia0Normal1Mild2Moderate3SevereTissue edema0Normal1Mild2Moderate3SevereEndometrial injury0Normal1Mild2Moderate3SevereEndometrial thickness0Normal2Thickened2ThinnedNeutrophil infiltration(cells/field)00–112–526–10311–20Total score range: 0–14 Table 1Histopathological scoring criteriaCriterionScoreDescriptionTissue hyperemia0Normal1Mild2Moderate3SevereTissue edema0Normal1Mild2Moderate3SevereEndometrial injury0Normal1Mild2Moderate3SevereEndometrial thickness0Normal2Thickened2ThinnedNeutrophil infiltration(cells/field)00–112–526–10311–20Total score range: 0–14 Histopathological scoring criteria Total score range: 0–14 Hematological analysis of systemic inflammation Peripheral blood samples were collected via the orbital venous plexus into EDTA-coated tubes and analyzed within 2 h using an automated hematology analyzer (BC-2800Vet, Mindray, China). White blood cell and lymphocyte counts were quantified to assess systemic inflammatory responses. Evaluation of neutrophil infiltration and oxidative stress Uterine tissues were homogenized in ice-cold phosphate-buffered saline (1:10, w/v) and centrifuged to obtain supernatants. MPO activity was measured using a commercial assay kit (Solarbio, BC5715, Beijing, China) according to the manufacturer’s instructions as an index of neutrophil infiltration. MDA levels were quantified using a commercial kit (Solarbio, BC6415, Beijing, China) to assess lipid peroxidation. SOD activity was measured using a commercial kit (Solarbio, BC5165, Beijing, China), and CAT activity was determined using a commercial kit (Solarbio, BC0205, Beijing, China) to evaluate antioxidant capacity. Gene expression analysis by RT-qPCR Total RNA was extracted from uterine tissues using TRIzol reagent, and complementary DNA (cDNA) was synthesized with the Evo M-MLV Reverse Transcription Kit (Accurate Biology, China) according to the manufacturer’s instructions. RT-qPCR was performed using the SYBR Green Pro HS Premix qPCR Kit (Accurate Biology, China) on an ABI QuantStudio real-time PCR system. Each reaction (total volume: 20 µL) contained 10 µL of 2 × SYBR Green Pro HS Premix, 0.4 µL of each forward and reverse primer (10 µM), 2 µL of cDNA template, and 7.2 µL of nuclease-free water. The two-step thermal cycling program was as follows: initial denaturation at 95 °C for 30 s, followed by 40 cycles of denaturation at 95 °C for 5 s and annealing/extension at 60 °C for 30 s. Melt curve analysis was performed to confirm amplification specificity. Primer sequences are listed in Table 2. The relative expression levels of target genes were normalized to the internal reference gene β-actin and calculated using the 2−ΔΔCt method. Table 2Primer sequences used for RT-qPCRGene symbolAccession numberForward primer (5'-3')Reverse primer (5'-3')B-actinXM_021187106CTACCTCATGAAGATCCTGACCCACAGCTTCTCTTTGATGTCACTNF-αNM_001278601ACGCTCTTCTGTCTACTGAACTTCGGTTTGTGAGTGTGAGGGTCTGIL-1βNM_008361TCGCAGCAGCACATCAACAAGTCCACGGGAAAGACACAGGTAGIL-6NM_031168GAGAGGAGACTTCACAGAGGATACCTCATTTCCACGATTTCCCAGAGAACCOX2XM_021159633ATTCCAAACCAGCAGACTCATACTTGAGTTTGAAGTGGTAACCGBcl-2NM_026121GCCTCCTACTCTGGGGCTTAGTTGGGCTGTTACCAGGTGAABaxNM_007527GGCGAATTGGAGATGAACTGAAAGTAGAAGAGGGCAACCANrf2NM_010902.5AGCGGTAGTATCAGCCAGCCCAGTCCCTCAATAGCKeap1NM_001110306.1GATATGAGCCAGAGCGGGACCATACAGCAAGCGGTTGAGCHO-1NM 010442.2TGTTGTTGCGCTCTATCTCCGTACACATCCAAGCCGAGiCCGA Table 2Primer sequences used for RT-qPCRGene symbolAccession numberForward primer (5'-3')Reverse primer (5'-3')B-actinXM_021187106CTACCTCATGAAGATCCTGACCCACAGCTTCTCTTTGATGTCACTNF-αNM_001278601ACGCTCTTCTGTCTACTGAACTTCGGTTTGTGAGTGTGAGGGTCTGIL-1βNM_008361TCGCAGCAGCACATCAACAAGTCCACGGGAAAGACACAGGTAGIL-6NM_031168GAGAGGAGACTTCACAGAGGATACCTCATTTCCACGATTTCCCAGAGAACCOX2XM_021159633ATTCCAAACCAGCAGACTCATACTTGAGTTTGAAGTGGTAACCGBcl-2NM_026121GCCTCCTACTCTGGGGCTTAGTTGGGCTGTTACCAGGTGAABaxNM_007527GGCGAATTGGAGATGAACTGAAAGTAGAAGAGGGCAACCANrf2NM_010902.5AGCGGTAGTATCAGCCAGCCCAGTCCCTCAATAGCKeap1NM_001110306.1GATATGAGCCAGAGCGGGACCATACAGCAAGCGGTTGAGCHO-1NM 010442.2TGTTGTTGCGCTCTATCTCCGTACACATCCAAGCCGAGiCCGA Primer sequences used for RT-qPCR Protein expression analysis by Western blot Total protein was extracted from uterine tissues using RIPA lysis buffer supplemented with phenylmethylsulfonyl fluoride (PMSF), and the protein concentrations were determined by the bicinchoninic acid (BCA) assay. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto polyvinylidene fluoride (PVDF) membranes. Following blocking with 5% non-fat milk, the membranes were sequentially incubated with primary antibodies and the immunoreactive signals were visualized using an enhanced chemiluminescence (ECL) detection system. Gut microbiota analysis Cecal contents were aseptically collected from individual mice immediately after sacrifice, rapidly snap-frozen in liquid nitrogen, and stored at -80 °C until subsequent analysis. Total microbial DNA was extracted using a commercial DNA extraction kit in accordance with the manufacturer’s instructions. The V3-V4 hypervariable regions of the bacterial 16 S ribosomal RNA (rRNA) gene were amplified using universal primers and sequenced on an Illumina sequencing platform. Raw sequencing reads were subjected to quality filtering and further processed using QIIME software (version 2022.2), and operational taxonomic units (OTUs) were clustered at a 97% sequence similarity. Alpha diversity indices, including Shannon and Chao1, were calculated to evaluate microbial richness and diversity, while beta diversity was assessed by principal coordinate analysis (PCoA) based on Bray-Curtis distance matrices. Taxonomic classification of the sequences was performed using the SILVA database. Functional prediction of microbial communities was conducted using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) and annotated against the KEGG database. Statistical analysis Data are presented as mean ± standard deviation (SD). Statistical analyses were performed using GraphPad Prism software (version 10.4). Differences among multiple groups were evaluated using one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test for multiple comparisons. Statistical significance was defined as P < 0.05. In the figures, groups not sharing the same lowercase letters are considered significantly different. Results Network pharmacology suggests candidate targets and pathways of baicalin in endometritis As shown in Fig. 1, overlapping targets between baicalin and endometritis-related genes were identified through Venn analysis (Fig. 1A). The compound-target-pathway network identified multiple candidate targets of baicalin, including PTGS2 (COX-2), EGFR, PGR, NR5A1, and CNR2 (Fig. 1B). Among these, PTGS2/COX-2 was selected for experimental validation in this study. PPI analysis confirmed interactions among these targets (Fig. 1C). GO enrichment analysis indicated that these targets are primarily involved in key biological processes including transcriptional regulation, inflammatory response, and metabolic processes (Fig. 1D). KEGG pathway analysis further revealed that these targets are significantly enriched in multiple signaling pathways, including arachidonic acid metabolism, the estrogen signaling pathway, and the oxytocin signaling pathway (Fig. 1E). These computational predictions provided candidate targets and pathways for experimental validation. Fig. 1Network pharmacology analysis of candidate targets and pathways of baicalin in endometritis. A Venn diagram showing the overlapping targets between baicalin and endometritis-related genes. B Compound-target-pathway interaction network illustrating the multi-target characteristics of baicalin. C PPI network of the overlapping targets. D GO enrichment analysis of overlapping targets, including biological process (BP), cellular component (CC), and molecular function (MF). E KEGG pathway enrichment analysis showing significantly enriched signaling pathways Network pharmacology analysis of candidate targets and pathways of baicalin in endometritis. A Venn diagram showing the overlapping targets between baicalin and endometritis-related genes. B Compound-target-pathway interaction network illustrating the multi-target characteristics of baicalin. C PPI network of the overlapping targets. D GO enrichment analysis of overlapping targets, including biological process (BP), cellular component (CC), and molecular function (MF). E KEGG pathway enrichment analysis showing significantly enriched signaling pathways Baicalin alleviates T. pyogenes-induced uterine injury and inflammation in mice Based on the predicted targets, in vivo experiments were conducted to assess the protective effects of baicalin. As shown in Fig. 2, mice in the TP group displayed marked uterine morphological abnormalities, including obvious swelling and structural disruption, compared with the CON group; these abnormalities were markedly alleviated following baicalin treatment (Fig. 2A). Histopathological examination revealed that the CON group retained an intact endometrial architecture with well-organized glands, whereas the TP group showed marked epithelial damage, glandular disorganization, and extensive inflammatory cell infiltration, all of which were markedly improved in the BAI group (Fig. 2A). In addition, the uterine index and histopathological scores were significantly increased in the TP group and notably decreased following baicalin treatment (Fig. 2B, C). Hematological analysis revealed that white blood cell (WBC) and lymphocyte counts were significantly increased in the TP group but decreased in the BAI group (Fig. 2D, E). This was accompanied by a marked elevation in MPO activity in the TP group, which was significantly reduced after baicalin treatment (Fig. 2F). Consistently, the mRNA expression levels of pro-inflammatory factors, including TNF-α, IL-1β, IL-6, and COX-2, were significantly upregulated in the TP group compared with the CON group, whereas baicalin treatment markedly downregulated their expression (Fig. 2G-J). Fig. 2Baicalin attenuates uterine injury and inflammatory responses in T. pyogenes-induced endometritis. A Representative images of uterine morphology and hematoxylin and eosin (H&E) staining of uterine tissues (low magnification, 20 ×; high magnification, 40 ×). B Uterine index. C Histopathological scoring of uterine tissues based on the criteria described in Table 1 (total score range: 0–14). D-E WBC count (D) and lymphocyte count (E). F MPO activity. G-J Relative mRNA expression levels of TNF-α (G), IL-1β (H), IL-6 (I), and COX-2 J. Data are presented as mean ± SD (n = 10). Different lowercase letters indicate statistically significant differences (P < 0.05) Baicalin attenuates uterine injury and inflammatory responses in T. pyogenes-induced endometritis. A Representative images of uterine morphology and hematoxylin and eosin (H&E) staining of uterine tissues (low magnification, 20 ×; high magnification, 40 ×). B Uterine index. C Histopathological scoring of uterine tissues based on the criteria described in Table 1 (total score range: 0–14). D-E WBC count (D) and lymphocyte count (E). F MPO activity. G-J Relative mRNA expression levels of TNF-α (G), IL-1β (H), IL-6 (I), and COX-2 J. Data are presented as mean ± SD (n = 10). Different lowercase letters indicate statistically significant differences (P < 0.05) Baicalin alleviates oxidative stress and apoptosis in T. pyogenes-induced endometritis To further investigate the protective mechanisms of baicalin, oxidative stress markers and apoptosis-related signaling were examined. As shown in Fig. 3A-C, antioxidant enzyme activities (CAT and SOD) were significantly reduced, whereas MDA levels were markedly elevated in the TP group compared with the CON group. Baicalin treatment significantly restored CAT and SOD activities while reducing MDA levels. Furthermore, T. pyogenes infection significantly downregulated Nrf2 and HO-1 mRNA expression and upregulated Keap1 mRNA expression, whereas these changes were markedly reversed following baicalin treatment (Fig. 3D-F). Fig. 3Baicalin alleviates oxidative stress and apoptosis in T. pyogenes-induced endometritis. A-C Activities of catalase (CAT) (A) and superoxide dismutase (SOD) (B), and the level of malondialdehyde (MDA) (C) in uterine tissues. D-F Relative mRNA expression levels of Nrf2 (D), Keap1 (E), and HO-1 (F). G-I Relative mRNA expression levels of Bax (G), Bcl-2 (H), and the Bax/Bcl-2 mRNA ratio (I). J-L Quantification of Bax protein expression normalized to β-actin (J), Bcl-2 protein expression normalized to β-actin (K), and the Bax/Bcl-2 protein ratio (L). M Representative Western blot images of Bax and Bcl-2 protein expression, with β-actin as the loading control. Data are presented as mean ± SD (n = 10). Different lowercase letters indicate statistically significant differences (P < 0.05) Baicalin alleviates oxidative stress and apoptosis in T. pyogenes-induced endometritis. A-C Activities of catalase (CAT) (A) and superoxide dismutase (SOD) (B), and the level of malondialdehyde (MDA) (C) in uterine tissues. D-F Relative mRNA expression levels of Nrf2 (D), Keap1 (E), and HO-1 (F). G-I Relative mRNA expression levels of Bax (G), Bcl-2 (H), and the Bax/Bcl-2 mRNA ratio (I). J-L Quantification of Bax protein expression normalized to β-actin (J), Bcl-2 protein expression normalized to β-actin (K), and the Bax/Bcl-2 protein ratio (L). M Representative Western blot images of Bax and Bcl-2 protein expression, with β-actin as the loading control. Data are presented as mean ± SD (n = 10). Different lowercase letters indicate statistically significant differences (P < 0.05) To evaluate apoptosis, the mRNA expression levels of Bax and Bcl-2, together with the Bax/Bcl-2 mRNA ratio, were determined. Compared with the CON group, the TP group exhibited significantly increased Bax expression, decreased Bcl-2 expression, and an elevated Bax/Bcl-2 ratio. Baicalin treatment significantly reversed these alterations (Fig. 3G-I). Consistent with the mRNA results, Western blot analysis showed that T. pyogenes infection increased Bax protein expression, decreased Bcl-2 protein expression, and significantly elevated the Bax/Bcl-2 protein ratio, whereas baicalin treatment effectively reversed these changes (Fig. 3J-M). Baicalin treatment is associated with changes in gut microbial composition and diversity in T. pyogenes-induced endometritis To investigate the impact of baicalin treatment on the gut microbiota, 16 S rRNA gene sequencing of cecal contents was performed. Microbial profiles differed markedly among groups (Fig. 4). At the phylum level, T. pyogenes infection increased the relative abundance of Bacteroidota and reduced that of Firmicutes, with additional changes in Spirochaetota and Thermodesulfobacteriota. At the genus level, pro-inflammatory taxa including Bacteroides, Porphyromonas, and Streptococcus were enriched, whereas beneficial genera such as Lactobacillus and Clostridium were reduced. Baicalin treatment partially reversed these infection-induced shifts, with the microbial composition of the BAI group trending toward that of the CON group (Fig. 4A, B). Venn diagram analysis revealed distinct patterns of shared and unique OTUs among groups, indicating infection- and treatment-related remodeling of microbial community membership (Fig. 4C). Alpha diversity analysis demonstrated significant differences in microbial richness and diversity among groups (Fig. 4D), and PICRUSt-based functional prediction revealed significant differences in the inferred enrichment of metabolic and cellular processes (Fig. 4E, F). Beta diversity analysis, including hierarchical clustering and PCoA, confirmed distinct separation of microbial communities among the CON, TP, and BAI groups (Fig. 4G-I), further supported by intra-group distance comparisons (Fig. 4J). Fig. 4Baicalin treatment alters gut microbial composition and diversity in T. pyogenes-induced endometritis. A, B Relative abundance of microbial communities at the phylum (A) and genus (B) levels. C Venn diagram showing shared and unique OTUs among groups. D Alpha diversity indices of microbial communities. E, F Functional prediction of microbial communities based on KEGG pathway analysis. G-I Beta diversity analysis, including clustering and PCoA. J Comparison of intra-group distance differences. Data are presented as mean ± SD (n = 4). Different lowercase letters indicate statistically significant differences (P < 0.05) Baicalin treatment alters gut microbial composition and diversity in T. pyogenes-induced endometritis. A, B Relative abundance of microbial communities at the phylum (A) and genus (B) levels. C Venn diagram showing shared and unique OTUs among groups. D Alpha diversity indices of microbial communities. E, F Functional prediction of microbial communities based on KEGG pathway analysis. G-I Beta diversity analysis, including clustering and PCoA. J Comparison of intra-group distance differences. Data are presented as mean ± SD (n = 4). Different lowercase letters indicate statistically significant differences (P < 0.05) Discussion Endometritis is widely recognized as a pathogen-induced condition involving dysregulated inflammatory signaling, disruption of redox homeostasis, and altered host-microbiota interactions, including both local uterine and distal gut microbial communities [32]. In this study, network pharmacology provided a systems-level framework, suggesting that baicalin targets key nodes, including PTGS2, EGFR, and PGR, with significant enrichment in arachidonic acid metabolism, estrogen signaling, and oxytocin signaling pathways. Among these targets, PTGS2 (COX-2) functions as a key rate-limiting enzyme in prostaglandin synthesis and is transcriptionally regulated by NF-κB under inflammatory conditions [33–35]. In agreement with these predictions, T. pyogenes infection significantly increased COX-2 expression as well as the levels of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6, suggesting activation of a classical NF-κB-mediated inflammatory cascade [36, 37]. These findings were further supported by elevated MPO activity and increased circulating WBC and lymphocyte counts, reflecting both local neutrophil infiltration and systemic inflammatory activation [38–40]. Histopathological observations confirmed severe endometrial damage, including epithelial disruption and glandular disorganization. Notably, treatment with baicalin significantly suppressed these inflammatory parameters, suggesting interference with upstream inflammatory transcriptional programs, thereby limiting COX-2-mediated prostaglandin amplification and subsequent immune cell recruitment [41]. Whether other predicted targets such as EGFR, PGR, NR5A1, and CNR2 contribute to tissue repair or hormonal regulation remains to be tested. Thus, the network pharmacology analysis should be viewed as hypothesis-generating and only partially validated. In addition to inflammatory activation, oxidative stress serves as a key amplifying mechanism that links immune responses to cellular damage in endometritis [42, 43]. In this study, T. pyogenes infection markedly elevated MDA levels while reducing SOD and CAT activities, reflecting excessive ROS accumulation and compromised antioxidant defense capacity [44]. Mechanistically, this imbalance is closely linked to disruption of the Nrf2/Keap1/HO-1 signaling axis. Under physiological conditions, Nrf2 is bound by Keap1 and targeted for proteasomal degradation [45]. In contrast, oxidative stress induces conformational changes in Keap1, leading to Nrf2 stabilization, nuclear translocation, and subsequent activation of antioxidant gene expression [46]. Interestingly, this resulted in aberrant Keap1 upregulation alongside suppression of Nrf2 and HO-1, suggesting that sustained inflammatory stress overrides the canonical Nrf2 activation and consequently impairs antioxidant defense [47]. Notably, baicalin counteracted this effect by downregulating Keap1 and restoring Nrf2/HO-1 expression, thereby reactivating antioxidant transcriptional programs [48]. Functionally, this was linked to decreased lipid peroxidation and restoration of antioxidant enzyme activity [49, 50]. Moreover, oxidative stress compromised mitochondrial integrity, as indicated by increased Bax and reduced Bcl-2 expression in the infected group, resulting in an elevated Bax/Bcl-2 ratio and mitochondrial apoptosis pathway [51]. Treatment with baicalin effectively restored these alterations to normal levels, suggesting that its antioxidant effects are associated with the stabilization of mitochondrial function and inhibition of the apoptotic cascades [52, 53]. In summary, these findings suggest that baicalin disrupts the oxidative stress-apoptosis amplification loop, thereby reducing oxidative damage and preserving cellular viability [54]. Notably, the aforementioned inflammatory and redox alterations were accompanied by significant changes in the gut microbiota composition, which may interact with host immune and metabolic pathways [55, 56]. In this study, T. pyogenes infection was associated with substantial shifts in the gut microbial composition, with an increased relative abundance of Bacteroidota and a reduction in Firmicutes, accompanied by changes in Spirochaetota and Thermodesulfobacteriota. At the genus level, pro-inflammatory taxa such as Bacteroides, Porphyromonas, and Streptococcus were significantly enriched, whereas beneficial genera including Lactobacillus and Clostridium showed a significant reduction. These compositional shifts are noteworthy in the context of endometritis pathophysiology. The decrease in Lactobacillus, a genus known for its anti-inflammatory properties and ability to maintain epithelial barrier integrity, may compromise mucosal defense. Conversely, the enrichment of Bacteroides and Porphyromonas, which are potential sources of LPS, may contribute to sustained TLR4 activation and inflammatory cytokine production. The partial reversal of these taxa by baicalin suggests a potential modulatory effect on the gut ecosystem that accompanies the anti-inflammatory action, although the functional significance of these specific microbial changes requires further targeted investigation. These alterations in microbial composition have important functional implications. Pro-inflammatory bacteria can produce lipopolysaccharide (LPS), which activates the TLR4/NF-κB pathway and promotes cytokine production. In contrast, the reduction of SCFA-producing bacteria decreases the levels of key metabolites such as butyrate, which have been shown to enhance epithelial barrier function, inhibit inflammation, and activate the Nrf2 signaling pathway [57, 58]. However, the directionality of these relationships cannot be determined from the current study design. Baicalin treatment was associated with a decrease in pro-inflammatory taxa and an increase in beneficial bacteria, along with PICRUSt-predicted differences in microbial functional potential related to lipid and amino acid metabolism [59, 60]. Whether these microbial shifts contribute causally to the therapeutic effects or are secondary to the improved host condition remains an open question. These findings suggest that microbiota-derived metabolites are plausible mediators linking microbial composition to host signaling pathways, although direct measurement of SCFAs, LPS, and other metabolites is required to validate this hypothesis [61]. Based on the integrated findings, we propose that baicalin exerts therapeutic effects primarily through suppression of inflammatory mediators and activation of Nrf2-mediated antioxidant responses. The observed upregulation of COX-2 and pro-inflammatory cytokines is consistent with NF-κB pathway activation, although direct evidence of NF-κB phosphorylation or TLR4 involvement was not assessed in this study. Notably, these protective effects were accompanied by alterations in the gut microbiota composition, including a reduction in pro-inflammatory taxa and an enrichment of beneficial genera within the gut microbiota. Although it is plausible that microbial metabolites such as SCFAs contribute to the anti-inflammatory and antioxidant effects, the current study design does not establish causality. Based on the above findings, a schematic model is proposed to illustrate the protective mechanisms of baicalin in T. pyogenes-induced endometritis (Fig. 5). Fig. 5Schematic summary of the protective effects of baicalin against T. pyogenes-induced endometritis. Baicalin suppresses inflammation and oxidative stress through the Nrf2/Keap1/HO-1 pathway and reduces apoptosis. These effects are accompanied by alterations in gut microbiota Schematic summary of the protective effects of baicalin against T. pyogenes-induced endometritis. Baicalin suppresses inflammation and oxidative stress through the Nrf2/Keap1/HO-1 pathway and reduces apoptosis. These effects are accompanied by alterations in gut microbiota This study has several limitations. The experimental design lacked a baicalin-only group and microbiota-targeted controls (e.g., antibiotic depletion, fecal microbiota transplantation), which precludes causal inference regarding the role of the gut microbiota. In addition, dose-response and time-course assessments were not performed. Future studies incorporating these controls are necessary to establish causality and optimize the therapeutic regimen. Conclusion In summary, this study demonstrated that baicalin treatment was accompanied by shifts in gut microbiota composition, including an increase in beneficial genera and a decrease in pro-inflammatory taxa, although a direct causal role for these microbial changes remains to be experimentally established. Crucially, baicalin effectively alleviated T. pyogenes-induced endometritis by suppressing inflammation, reducing oxidative stress, and inhibiting apoptosis, likely through activation of the Nrf2/Keap1/HO-1 pathway. These preclinical findings support further evaluation of baicalin as a candidate adjunct or alternative strategy for endometritis. Supplementary Information Supplementary Material 1. Supplementary Material 1.